NCT06024681 - Fecal Microbiota Transplantation (FMT) & Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Study overview

This is a non-randomized basic science clinical trial studying Fecal Microbiota Transplantation (FMT) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD)

Primary outcome measures

Change in faecal microbiome composition, change in gut microbial metabolite composition

Results

There are no published results as of March 2026

…

AI Chat

11/5/2026

Chat with our artificial intelligence:

Start chat!